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Abstract
a-Crystallins, initially described as the major structural proteins of the lens, belong to the small heat shock protein family.
Apart from their function as chaperones, a-crystallins are involved in the regulation of intracellular apoptotic signals. aA-
and aB-crystallins have been shown to interfere with the mitochondrial apoptotic pathway triggering Bax pro-apoptotic
activity and downstream activation of effector caspases. Differential regulation of a-crystallins has been observed in several
eye diseases such as age-related macular degeneration and stress-induced and inherited retinal degenerations. Although
the function of a-crystallins in healthy and diseased retina remains poorly understood, their altered expression in
pathological conditions argue in favor of a role in cellular defensive response. In the Rpe652/2 mouse model of Leber’s
congenital amaurosis, we previously observed decreased expression of aA- and aB-crystallins during disease progression,
which was correlated with Bax pro-death activity and photoreceptor apoptosis. In the present study, we demonstrated that
a-crystallins interacted with pro-apoptotic Bax and displayed cytoprotective action against Bax-triggered apoptosis, as
assessed by TUNEL and caspase assays. We further observed in staurosporine-treated photoreceptor-like 661W cells stably
overexpressing aA- or aB-crystallin that Bax-dependent apoptosis and caspase activation were inhibited. Finally, we
reported that the C-terminal extension domain of aA-crystallin was sufficient to provide protection against Bax-triggered
apoptosis. Altogether, these data suggest that a-crystallins interfere with Bax-induced apoptosis in several cell types,
including the cone-derived 661W cells. They further suggest that aA-crystallin-derived peptides might be sufficient to
promote cytoprotective action in response to apoptotic cell death.
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Introduction
a-Crystallins, the major structural proteins of the mammalian
lens, encompass aA- and aB-crystallins, which are encoded by
separate genes [1]. The two a-crystallins have molecular masses
around 20 kDa each and share 55% amino acid identity. Their
molecular structure is similar, containing three distinct domains: a
highly conserved central a-crystallin domain of around 90 amino
acids, flanked by a variable hydrophobic N-terminal domain and a
hydrophilic C-terminal extension containing a conserved sequence
motif [2–4]. a-Crystallins belong to the small heat shock protein
family of molecular ATP-independent chaperones. In mature lens
fiber cells, they binds improperly folded proteins thereby
preventing subsequent formation of light scattering aggregates
[5]. Interactions between a-crystallins and putative substrates
involve exposure of hydrophobic surfaces. However, emerging
data support the idea that many sites may contribute to substrate
interactions and that binding may be different according to the
nature of the substrates [4,6].
Besides their chaperone-like activity [1,7], a-crystallins play a
critical role in modulating various cellular processes such as
oxidative stress, neuroprotection and apoptosis pathways, either
promoting survival or inhibiting cell death [8]. In human lens-
derived epithelial cell line, a-crystallins interfere with UVA-
induced apoptosis through different mechanisms, including
PKCa, Raf/MEK/ERK and Akt signaling pathways. While aB-
crystallin is able to abrogate apoptosis through repression of Raf/
MEK/ERK signal, aA-crystallin activates the Akt surviving
pathway to inhibit triggered apoptosis [9]. In addition, aA-
crystallin has been shown to inhibit apoptosis by enhancing
phosphoinositide 3 kinase (PI3K) activity, which was related to its
chaperone activity [10]. It has been observed that a-crystallins
counteract the mitochondrial apoptotic pathway triggering the
translocation of Bax at the mitochondria, the release of
mitochondrial cytochrome C in the cytosol and the subsequent
activation of downstream caspases including Caspase-3 [11]. In
lens epithelial cells, interaction of a-crystallins with pro-apoptotic
Bcl-2-related proteins and Caspase-3 prevents Bax and Bcl-XS
mitochondrial translocation and caspase activation [12,13]. They
display cytoprotective action against staurosporine (STS)- and
UVA-induced apoptosis [14,15,9]. a-Crystallins protect cells from
metabolic stress [16] as well as apoptosis induced by various stress
factors such as STS [15,17], TNF [15,18], calcium [19], and
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hydrogen peroxide [20,21]. aB-crystallin can inhibit apoptosis
induced by TRAIL [22], DNA-damaging agent and growth factor
deprivation [23,24].
Microarray and proteome expression studies highlighted that
aA- and aB-crystallins are expressed in normal and pathological
retina [25–27]. Both proteins are detected in the ganglion cell
layer as well as in the outer and inner nuclear layers of the retina
[25]. During the course of retinal degeneration, a-crystallin
expression is impaired in inherited retinal diseases in RCS rat
[28,29] and rd mouse [27,30], after ischemia-reperfusion injury
[31], following exposure to light injury [32], and in age-related
macular degeneration (ARMD) [33]. Altered regulation of a-
crystallins in ocular pathologies suggests that they may impact on
the outcome of the related diseases. Disruption of aA-crystallin
accentuates photoreceptor apoptosis and retinal degeneration in
chemically-induced hypoxia [34] and in experimental uveitis
[35,36]. The current observations argue in favor of a-crystallins as
part of a cellular protective response to the stress of the diseased
retina.
We previously reported that the altered regulation of a-
crystallins was correlated with triggering of the Bcl-2-apoptotic
pathway during progression of the disease in the Rpe652/2 mouse
model of Leber’s congenital amaurosis (LCA), an autosomal
recessive form of retinitis pigmentosa (RP) [37]. This decrease was
correlated with mitochondrial translocation of pro-apoptotic Bax
and photoreceptor apoptosis [38]. We further demonstrated the
direct role of pro-apoptotic Bax in the apoptosis of rod
photoreceptors in early [39] and late [40] stages of the disease.
In the present study, we proposed to analyze the anti-apoptotic
function of a-crystallins against Bax-mediated apoptosis. We
further assessed which domain of aA-crystallin was involved in
protecting against Bax-triggered apoptosis.
Materials and Methods
Cloning and Plasmids
The mouse aA (aA)- and aB (aB)-crystallin cDNAs were
amplified by RT-PCR from mouse retina mRNA using the
following primers: 59-ATGGACGTCACCATTCAGCATCCT
TGGTTCAAGCGTGCCCTGG-39 (aA-for), 59-TCAGGACGA
GGGTGCAGAGCTG-39 (aA-rev), 59-ATGGACATCGCCAT
CCACCACCCCTGGATCCGGCGCCCCTTC-39 (aB-for), 59-
CTACTTCTTAGGGGCTGCGGCG-39 (aB-rev). The cDNAs
were then inserted into pGEM-T cloning vector (pGEMH-T Easy
Vector Systems; Promega, Du¨bendorf, Switzerland). NotI-digested
aA- and aB-crystallin inserts from pGEM-T constructs were
further subcloned into pcDNA3.1 expression vector (pcDNA3.1-
aA/aB) at the NotI site. The pRluc-aA-crystallin and pRluc-aB-
crystallin fusion constructs were created by PCR and fused in
frame at the N-terminus of luciferase (pRluc-N2 vector) at the
BglII and XhoI sites, using the following primers:
59-gatcagatctgccaccatggacgtcaccattcag-39 (BglII-aA-for), 59-
gatcctcgagggacgagggtgcagagc-39 (XhoI-aA-rev);
59-gatcagatctgccaccatggacatcgccatccac-39 (BglII-aB-for), 59-
gatcctcgagcttcttaggggctgcggc-39 (XhoI-aB-rev).
The pRluc-aA-crystallin mutant constructs were generated in
the same way using the following primers:
aA_1-116: 59-GATCAGATCTGCCACCATGGACGTCAC-
CATTCAG-39 (BglII-aA-for), 59-GATCCTCGAGACGGTGAA
ATTCAC-39 (XhoI-aA_1-116-rev);
aA_117-173: 59-GATCAGATCTGCCACCATGCGCTACC
GTCTG-39 (BglII-aA_117-173-for), 59-GATCCTCGAGGGAC-
GAGGGTGCAGAGC-39 (XhoI-aA-rev);
aA_1-89: 59-GATCAGATCTGCCACCATGGACGTCACC
ATTCAG-39 (BglII-aA-for), 59-GATCCTCGAGTACCTTCAC
GGTGAGGTC-39 (XhoI-aA_1-89-rev);
aA_90-143: 59-GATCAGATCTGCCACCATGCTGGAGGA
TTTTGTGGAG-39 (BglII-aA_90-143-for), 59-GATCCTCGAG
GCCAGAGAAGGTCAGCATG-39 (XhoI-aA_90-143-rev);
aA_144-173: 59-GATCAGATCTGCCACCATGCCCAAGG
TCCAGTCC-39 (BglII-aA_144-173-for), 59-GATCCTCGAGG-
GACGAGGGTGCAGAGC-39 (XhoI-aA-rev);
aA_64-143: 59-GATCAGATCTGCCACCATGGTCCGATC
TGAC-39 (BglII-aA_64-143-for), 59-GATCCTCGAGGCCAGA-
GAAGGTCAGCATG-39 (XhoI-aA_64-143-rev).
The bicistronic lentiviral vector pWPI (www.addgene.org,
Addgene plasmid 12254), generously provided by Dr. D. Trono
(Ecole Polytechnique Fe´de´rale de Lausanne (EPFL), Lausanne,
Switzerland), was used to subclone PCR-amplified aA-myc and
aB-myc inserts at the PacI site (pWPI-aA and pWPI-aB) using the
following primers: 59-GATCTTAATTAAGCCACCATGGACG
TCACCATTCAG-39 (PacI-aA-for), 59-GATCTTAATTAATCA
CAGATCTTCTTCAGAAATAAGTTTTTGTTCGGACGAG
GGTGCAGAGCTGG-39 (PacI-aA-myc-rev), 59-GATCTTAAT-
TAAGCCACCATGGACATCGCCATCCAC-39 (PacI-aB-for),
59-GATCTTAATTAATCACAGATCTTCTTCAGAAATAAG
TTTTTGTTCCTTCTTAGGGGCTGCGGCG-39 (PacI-aB-
myc-rev). pcDNA3-Bax plasmid was generously provided by Dr.
S. Matsuyama (Case Western Reserve University, Cleveland,
USA).
Cell culture and transient transfection
Embryonic kidney (HEK) 293T cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (PAA Laboratories E15-883,
Pasching, Austria) supplemented with 25 mM Hepes, 10% FBS
(BiowhittakerH DE14-802F, Lonza Verviers SPRL, Verviers,
Belgium), 100 U/ml penicillin and 100 mg/ml streptomycin (Life
Technologies Europe/GIBCO, Zoug, Switzerland). Mouse pho-
toreceptor-derived 661W cell line was grown in DMEM (PAA
Laboratories E15-883) supplemented with 25 mM Hepes, 1 mM
sodium pyruvate, 10% FBS (BiowhittakerH DE14-802F), 0.6 mM
ß-mercaptoethanol (Applichem, Darmstadt, Germany), 100 U/ml
penicillin and 100 mg/ml streptomycin (Life Technologies). 661W
cells were generously provided by Dr. M. Al-Ubaidi (University of
Oklahoma, Olkahoma City, USA) [41].
293T cells were transiently transfected with the calcium
phosphate method (ProFectionH, Promega) or with the cationic
polymer method (jetPEITM, Polyplus-transfection, Illkirch,
France). Cells were transfected with the following total amount
of plasmids: 3.5 mg and 2 mg using ProFectionH and jetPEITM,
respectively, in 12-well plates (TPP, Trasadingen, Switzerland),
0.25 mg using jetPEITM in 96-well plates (TPP) and 8 mg using
jetPEITM in p100 plates (TPP). 661W cells in p100 plates were
transiently transfected with 24 mg of plasmids using the cationic
lipid method (Lipofectamine LTXH/PLUSTM, Life Technologies).
To keep the total amount of transfected DNA constant,
appropriate quantities of empty plasmids were added in all
experiments. All plasmids were prepared on NucleoBondH PC500
columns (Macherey-Nagel, Du¨ren, Germany).
Preparation of lentiviral vectors and transduction of
661W cells
Approximately 1000-fold concentrated, high titer stocks of
lentiviral vectors packaged by the multiply attenuated lentivirus
pCMVDR8.74 and pseudotyped with the vesicular stomatitis
virus-G (VSV-G) envelope protein (plasmid pMD2.G) were
obtained by transient co-transfection of 293T cells with the
a-Crystallin Cytoprotective Action
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corresponding lentiviral expression vectors (pWPI, pWPI-aA and
pWPI-aB), as previously described [42,43]. The pWPI bicistronic
vector allows for simultaneous expression of a transgene and GFP
fluorescent marker, the latter being inserted downstream of an
internal ribosome entry site from encephalomyocarditis virus
(IRES-EMCV). Approximately 90–95% of the 661W cells were
transduced with the recombinant lentiviruses, according to GFP
fluorescence tracking, and stably expressed the target genes as
assessed by immunofluorescence and western blotting.
Co-immunoprecipitation
Cleaning of the antibody used for co-immunoprecipitation (co-
IP) was done using the Melon Gel IgG purification support to
remove gelatin from the IgG sample (PierceH Antibody Clean-up
kit; Thermo Fisher Scientific, Lausanne, Switzerland). Co-IP was
performed according to manufacturer’s instructions (PierceH Co-
Immunoprecipitation kit; Thermo Fisher Scientific). Briefly, 293T
cells grown in p100 plates were lysed in 500 ml IP lysis/wash buffer
containing freshly added Protease inhibitor cocktail tablets (Roche,
Rotkreuz, Switzerland). 1000 to 2000 mg of total proteins in 500 ml
final volume IP lysis/wash buffer were immunoprecipitated with
15 to 30 mg of pre-cleaned rabbit anti-Bax antibody (sc-493; Santa
Cruz Biotechnology, Heidelberg, Germany) coupled to Amino-
LinkH Plus Coupling Resin overnight at 4uC on a rotary wheel,
followed by 3 washes in IP lysis/wash buffer. The immunopre-
cipitated complex was then eluted in 30 to 60 ml of elution buffer.
Immunoprecipitated samples and whole cell extracts were resolved
on 12% SDS-PAGE and transferred on PVDF membranes
(Whatman/Schleicher & Schuell, Sanford, United Kingdom).
Membranes were blocked in 5% non-fat dried milk before being
immunoassayed to detect a-crystallins and Bax, using mouse
monoclonal anti-myc (diluted 1/10’000, from the Protein Expres-
sion Core Facility, EPFL, Lausanne, Switzerland) or rabbit
polyclonal anti-aA/aB-crystallin (diluted 1/1’000, ADI-SPA-224;
Enzo Life Sciences, Lausen, Switzerland) and rabbit polyclonal
anti-Bax (diluted 1/2’000, sc-493; Santa Cruz) antibodies,
respectively.
Western blot analysis
Cells in p100 plates were lysed in 200 ml RIPA buffer containing
freshly added Protease inhibitor cocktail tablets (Roche). Equiv-
alent amounts of protein, as determined by the colorimetric
Bradford protein assay (Bio-Rad Laboratories AG, Reinbach,
Switzerland), were resolved on 12% SDS-PAGE followed by
transfer on PVDF membrane (Whatman/Schleicher & Schuell).
Membranes were blocked in 5% non-fat dried milk before being
immunoassayed using mouse monoclonal antibodies directed
against myc (diluted 1/10’000; EPFL), ß-actin (diluted 1/10’000,
A5441; Sigma-Aldrich Chemie, Buchs, Switzerland) and luciferase
(diluted 1/1’000, L6003-20; USBiological, Swampscott, USA),
and rabbit polyclonal antibodies directed against GFP (diluted 1/
5’000, G1544; Sigma) and aA/aB-crystallin (diluted 1/1’000,
ADI-SPA-224; Enzo Life Sciences).
Caspase assays
Caspase-Glo assay (Caspase-GloH 3/7 Assay, Promega) was
performed according to manufacturer’s instruction. Briefly, 293T
cells in 96-well plate (76103 cells/well) were incubated in 100 ml/
well of Caspase-GloH 3/7 Reagent for 30 min at room temper-
ature (RT) in the dark before measuring the luminescent signal in
a plate-reading luminometer as directed by the luminometer
manufacturer. Caspase colorimetric assay (BioVision, Milpitas,
USA) was performed according to manufacturer’s instruction.
Briefly, 100 to 200 mg of proteins from cell extracts were incubated
in 200 mM of Caspase-3/-7-specific DEVD-pNA substrate for 1 h
at 37uC. Spectrophotometric detection of the chromophore p-
nitroanilide (pNA) liberated after caspase cleavage was quantified
using a microtiter plate reader at 400-/405-nm.
Terminal dUTP Nick End-Labeling (TUNEL) of fragmented
DNA
DNA strand breaks in cell nuclei were detected by TUNEL
assay, accroding to manufacturer’s instruction. Briefly, cells grown
on 0.1% gelatin-coated glass coverslips were fixed in 4%
paraformaldehyde (PFA)/phosphate-buffered saline (PBS) for
20 min at RT, permeabilized in 0.1% Triton X-100/0.1%
sodium citrate for 2 min on ice and incubated with terminal
deoxynucleotidyl transferase (TdT) and fluorescein-12-dUTP or
TMR-dUTP for 1 h at 37uC. Cells were also counterstained with
49,6-diamidino-2-phenylindole, dihydrochloride (DAPI; Life
Technologies) or Hoechst 33342 (Sigma) to identify cell nuclei.
Following 3 washes in PBS, coverslips were mounted in Citifluor
AF1 (Citifluor, London, United Kingdom) and viewed under a
fluorescence microscope (Olympus BX61) using appropriate
filters. For each condition, the number of TUNEL-positive
apoptotic cells relative to the number of DAPI-stained viable cells
was counted in three areas of the plated cells and the resulting
numbers from each experiment (n = 2–3) were averaged.
Luminescence ATP detection assay
Measure of cellular ATP content (ATPLiteTM, PerkinElmer)
was performed to assess cell viability following STS (Sigma)
treatment, according to manufacturer’s instruction. Briefly, 661W
cells in 96-well plate (76103 cells/well) were incubated in 50 ml/
well of mammalian cell lysis solution and 50 ml/well of substrate
solution, followed by 10 min incubation at RT in the dark before
measuring the luminescence in a plate-reading luminometer.
Immunofluorescence
Cells grown on 0.1% gelatin-coated coverslips were fixed in 4%
PFA/PBS for 20 min at RT, washed briefly with PBS and
permeabilized in 0.2% Triton X-100/PBS for 2 min. Cells were
then blocked in PBS with 10% normal goat serum (NGS, G9023;
Sigma) and 0.2% Triton X-100 (Sigma) for 1 h at RT.
Immunodetection was performed by incubation with primary
antibodies in PBS with 2% NGS and 0.2% Triton X-100
overnight at 4uC, followed by incubation with fluorochrome-
conjugated secondary antibody for 1 h at RT. Incubation with
non-immune immunoglobulin fraction (Sigma) of the same species
as the primary antibody was used as a negative control. Species
and dilutions of the antibodies used were as follows: rabbit anti-
aA/aB-crystallin (diluted 1/500, ADI-SPA-224; Enzo Life
Sciences, Lausen, Switzerland), mouse anti-myc (diluted 1/
1’000; EPFL), mouse anti-luciferase (diluted 1/100, L6003-20;
USBiological) and Alexa Fluor 594 goat anti-mouse IgG (diluted
1/1’000, A11005; Life Technologies). Following 3 washes in PBS,
coverslips were mounted in Citifluor AF1 (Citifluor). Cells were
counterstained with DAPI (Life Technologies) to identity cell
nuclei.
Imaging
Images were viewed under a fluorescence microscope equipped
with a digital camera (Olympus BX61; Olympus, Lausanne,
Switzerland) using appropriate filters.
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Figure 1. Expression of aA- and aB-crystallins in transiently transfected 293T cells. (A) Western blot analysis of aA- and aB-crystallin levels
24 h post-transfection. Fifty micrograms of total proteins from cell extracts were subjected to 12% SDS-PAGE and immunoassayed with anti-aA/aB-
crystallin to detect the overexpressed a-crystallins and with anti-ß-actin as a control of equal protein loading. (B) Immunofluorescence analysis with
anti-aA/aB-crystallin showing cytoplasmic expression of aA- (pcDNA3.1-aA) and aB- (pcDNA3.1-aB) crystallins 24 h post-transfection, while no
detection was observed in cells transfected with the empty plasmid (pcDNA3.1).
doi:10.1371/journal.pone.0055372.g001
a-Crystallin Cytoprotective Action
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Statistical analysis
All results were expressed as means 6 SEM of the indicated
number of experiments. Statistical significance was calculated with
the t-test.
Results
Anti-apoptotic activity of a-crystallins against Bax-
induced cell death
To evaluate the cytoprotective action of a-crystallins, we first
cloned both aA- and aB-crystallin cDNAs from mouse retina.
Protein expression was then assessed in 293T cells transfected for
24 h with either aA- or aB-crystallin. As shown by western blot
analysis, aA- and aB-crystallin proteins of the expected size were
detected in cells transiently transfected with pcDNA3.1-aA and
pcDNA3.1-aB constructs, respectively, while no protein was
observed in cells transfected with the empty pcDNA3.1 plasmid
(Fig. 1A). The cytoplasmic localization of the overexpressed aA-
and aB-crystallins was further observed by immunofluorescence
(Fig. 1B).
It has been shown in lens-derived epithelial cells that aA- and
aB-crystallins interacted with pro-apoptotic Bax and prevented
stress-induced apoptosis [13]. We thus investigated the interaction
of a-crystallins and Bax in vivo in 293T cells overexpressing aA- or
aB-crystallin. Cells were treated with 100 nM STS for 3 h before
performing co-immunoprecipitation to assess the interaction of
endogenous Bax with a-crystallins. Binding of Bax with both aA-
and aB-crystallins was confirmed in cells transfected with the
lentiviral vector expressing myc-tagged aA- (pWPI_aA) or aB-
(pWPI_aB) crystallin, whereas no protein was co-immunoprecip-
itated in cells transfected with the empty vector (pWIP) (Fig. 2).
The anti-apoptotic action of a-crystallins against Bax-induced
apoptosis was then assessed by caspase and TUNEL assays in
293T cells overexpressing a-crystallins and Bax. 293T cells were
initially transfected for 24 h with the empty plasmid (pcDNA3.1),
pcDNA3.1-aA-crystallin (aA) or pcDNA3.1-aB-crystallin (aB)
constructs, before to be co-transfected for 24 h with Bax. Forty-
eight hours post-transfection, TUNEL assay was performed using
fluorescein-12-dUTP to detect TUNEL-positive apoptotic cells. As
shown in Fig. 3A, dense green fluorescence staining of apoptotic
nuclei was observed in cells overexpressing Bax, whereas Bax-
triggered apoptosis was inhibited in the presence of either aA- or
aB-crystallin. The cytoprotective activity of a-crystallins against
Bax-triggered apoptosis was further confirmed in co-transfected
293T cells, by measuring Caspase-3/-7 activity using a lumino-
genic substrate containing the Caspase-3/-7-specific DEVD amino
acid sequence. Caspase activity was induced 3- to 6-fold in cells
overexpressing Bax 16 h and 24 h post-transfection, respectively.
However, Bax-induced caspase activity was inhibited by around
50% in the presence of either aA- (aA) or aB- (aB) crystallin
(Fig. 3B).
Staurosporine induced apoptosis in 661W cells
The cone-derived photoreceptor cell line 661W was initially
isolated from a mouse retina transformed with the SV40 T-antigen
under the control of the human interphotoreceptor retinol-binding
protein (IRBP) promoter [41]. These cells express cone-specific
markers including blue and green opsins, transducin (Gnat2) and
arrestin (Arr3) [44].
Staurosporine (STS), a protein kinase C inhibitor, preferentially
activates the mitochondrial apoptotic pathway relying on Bax and
caspase activation [11,45,46]. The effect of STS on 661W cell
viability was assessed following exposure to increasing concentra-
tions of the drug for 24 h. Cell viability was then evaluated by
TUNEL assay as well as by measuring cellular ATP content. As a
marker of cell viability, ATP is present in all metabolically active
cells and its intracellular concentration declines very rapidly when
cells die. Upon STS treatment, apoptotic cell death was induced in
a dose-dependent manner, as reflected by the increase in TUNEL-
positive apoptotic cells from 25 to 200 nM STS (Fig. 4A). A
massive reduction in cellular ATP content was observed in 661W
cells exposed to 25 nM STS and was further decreased at the
highest concentrations of the drug (Fig. 4B).
a-Crystallins were stably expressed in 661W cells
To evaluate the anti-apoptotic activity of a-crystallins in
photoreceptor-like 661W cells, we first generated stable cell lines
overexpressing aA- or aB-crystallin. To achieve this, 661W cells
were transduced with the recombinant lentiviruses overexpressing
aA-crystallin (pWPI_aA) or aB-crystallin (pWPI_aB), or with the
empty lentivirus (pWPI), and pools of transduced cells were
expanded (Fig. 5A). As observed by western blot analysis, aA- and
aB-crystallins were expressed in pWPI_aA- and pWPI_aB-
transduced 661W cells, respectively, while no expression of the
transgene was detected neither in cells transduced with the empty
lentivirus nor in non transduced cells. As a control of transduction
efficiency, all transduced cell lines expressed the GFP marker gene,
while no protein was visible in non-transduced 661W cells
(Fig. 5B). Immunofluorescence analysis showed that most of the
cells were transduced with the recombinant lentiviruses, as
reflected by GFP fluorescence and a-crystallin staining with anti-
myc antibody. In addition, a-crystallins were essentially localized
in the cytoplasm while GFP showed nuclear and cytoplasmic
localization (Fig. 5C). Of note, clonal populations of cells
overexpressed the transgenes with different levels of expression.
Figure 2. Interaction of a-crystallins with Bax in vivo. 293T cells
transiently transfected with the empty vector (pWPI), myc-tagged aA-
(pWPI_aA) or aB- (pWPI_aB) crystallin were further treated with 100 nM
STS for 3 h before co-immunoprecipitation with anti-Bax antibody. The
precipitated samples were then sequentially probed by western blot
using anti-myc and anti-Bax antibodies. IP: immunoprecipitated
samples (left panels); CE: 20 mg of total proteins from whole cell extract
(right panels).
doi:10.1371/journal.pone.0055372.g002
a-Crystallin Cytoprotective Action
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STS-induced apoptosis was prevented in 661W cells in
the presence of a-crystallins
To further assess whether a-crystallins may counteract Bax-
mediated apoptosis, 661W cells overexpressing aA- or aB-
crystallin were exposed to 100 nM STS for 16 h. In TUNEL
assay, using TMR-dUTP to detect DNA-strand breaks, STS-
triggered apoptosis was markedly reduced in the presence of aA-
and aB-crystallins, as compared with 661W cells transduced with
the empty lentivirus (Fig. 6A). We then investigated whether a-
crystallins may interfere with STS-induced activation of effector
caspases using a Caspase-3/-7 colorimetric assay. Following
exposure to STS, caspase activation was induced in 661W cells,
as reflected by a 5-fold increase in Caspase-3/-7 activity in pWPI-
transduced cells. However, caspase activity was inhibited in the
presence of a-crystallins, with around 50% and 20% reduction in
661W cells overexpressing aA- and aB-crystallins, respectively
(Fig. 6B).
The C-terminal extension domain of aA-crystallin was
sufficient to prevent Bax-induced apoptosis
a-Crystallins are characterized by a conserved a-crystallin
domain flanked by a N-terminal domain and a short C-terminal
extension [2–4]. To identify the domain of aA-crystallin sufficient
to protect against Bax-induced apoptosis, we generated deletion
mutants corresponding to distinct domains of aA-crystallin
(Fig. 7A). Fusion proteins were created in which full-length and
mutant aA-crystallins were fused in frame at the N-terminus of
luciferase.
Figure 3. Anti-apoptotic activity of a-crystallins against Bax-induced apoptosis. 293T cells were transiently co-transfected with pcDNA3-
Bax and with either the empty pcDNA3.1, pcDNA3.1-aA- (aA) or pcDNA3.1-aB (aB)-crystallin constructs. (A) TUNEL assay showing that Bax-triggered
apoptosis was inhibited in 293T cells overexpressing the a-crystallins, as reflected by the reduced number of TUNEL-positive apoptotic cells. Cell
nuclei were counterstained with Hoechst. (B) As assessed by luminescent caspase assay, Bax-induced Caspase-3/-7 activity was inhibited in the
presence of aA- (aA) and aB- (aB) crystallins 16 h and 24 h post-transfection. (* p,0.0001 by t-test for Bax versus aA/Bax and for Bax versus aB/Bax at
16 h and 24 h). Data are the mean 6 SE of three independent experiments, each performed in triplicates.
doi:10.1371/journal.pone.0055372.g003
a-Crystallin Cytoprotective Action
PLOS ONE | www.plosone.org 6 February 2013 | Volume 8 | Issue 2 | e55372
As 661W cells are low-efficient transfectable cells, we evaluated
the anti-apoptotic properties of aA-crystallin mutants in 293T cells
transiently transfected with the different constructs. Ectopic
expression of full-length and mutant aA-crystallins was verified
by western blot analysis (Fig. 7B). Bands of the expected size were
detected for wt and mutant proteins. A 34-kDa band correspond-
ing to luciferase was also observed in cells over-expressing the aA-
crystallin proteins, as well as in cells transfected with the empty
pRluc plasmid. This may be explained by translational leakiness as
the pRluc plasmid contains an internal ATG start codon at the N-
terminus of luciferase. As a control, no signal was detected in cells
transfected with the pcDNA3.1 plasmid. Immunofluorescence
analysis confirmed the cytoplasmic localization of the different
mutants, similarly to wt aA-crystallin (Fig. 7C).
The anti-apoptotic activity of the different aA-crystallin mutants
against Bax-induced apoptosis was then assessed in 293T cells co-
transfected with Bax and with wt or mutant aA-crystallins.
Twenty-four hours post-transfection, TUNEL assay was per-
formed to detect and count TUNEL-positive apoptotic cells. As
shown in Fig. 8, wt aA-crystallin (Bax/aA_wt) inhibited Bax-
triggered apoptosis (Bax/pRluc). Moreover, aA_90-143 mutant
was as efficient as wt protein to prevent apoptosis, while the C-
terminal extension aA_144-173 mutant significantly displayed
better protection than the full-length aA-crystallin. However, we
can not exclude that it may reflect differences in the levels of
expression of the corresponding proteins. In addition, N-terminal
aA_1-89 and aA_1-116 mutants, along with aA_64-143 mutant
containing the a-crystallin domain, did not protect against Bax-
induced apoptosis.
We further investigated whether the C-terminal extension
domain of aA-crystallin retained its capacity to bind Bax in vivo.
The interaction of full-length aA-crystallin or aA_144-173 mutant
with Bax was assessed by co-immunoprecipitation in 293T cells
over-expressing the aA-crystallin constructs and treated for 3 h
with 100 nM STS. As observed for full-length aA-crystallin
(aA_wt), the C-terminal extension domain (aA_144-173) was
sufficient to bind Bax, whereas no immunoprecipitated proteins
were observed in cells transfected with the empty vector (pRluc)
(Fig. 9).
Altogether these data suggested that the C-terminal extension of
aA-crystallin was sufficient to promote the anti-apoptotic action of
the protein through binding with Bax and preventing its activation
and translocation to the mitochondria.
Figure 4. STS-induced apoptosis in 661W cells. Dose-dependent induction of apoptosis in 661W cells exposed to increasing amounts of STS (25
to 200 nM) for 24 h, as depicted by (A) increased TUNEL-positive apoptotic cells and (B) decreased level of intracellular ATP content. Data are the
mean 6SE of at least four independent experiments, each performed in triplicates.
doi:10.1371/journal.pone.0055372.g004
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Discussion
In the current study, we reported the anti-apoptotic action of
aA- and aB-crystallins against Bax-triggered apoptosis. Indeed,
caspase-induced apoptosis was inhibited in 293T cells overex-
pressing a-crystallins, reflected by the inhibition of Caspase-3/-7
activity and the decrease in TUNEL-positive apoptotic cells. By
co-immunoprecipitation study, we further showed that aA- and
aB-crystallins directly interacted with pro-apoptotic Bax in vivo,
suggesting that a-crystallins exert their pro-survival action by
sequestering Bax in the cytoplasm to prevent its activation and
Figure 5. Stable expression of a-crystallins in 661W cells. (A) Schematic representation of the bicistronic pWPI lentiviral vector allowing for
pEF1a-driven simultaneous expression of the transgene (aA- or aB-crystallin) and IRES-mediated GFP fluorescent marker. (B) Western blot analysis of
aA- and aB-crystallins expressed in lentivirus-transduced 661W cells. Twenty-five micrograms of total proteins from cell extracts were subjected to
12% SDS-PAGE. Myc-tagged aA- and aB-crystallins were expressed in 661W cells transduced with the recombinant lentiviruses pWPI_aA and
pWPI_aB, respectively, while no transgene was detected in cells transduced with the empty lentivirus pWPI or in non transduced cells (2).
Membranes were further immunoassayed with anti-GFP as a control of transduction efficiency and with anti-ß-actin as a control of equal protein
loading. (C) Immunofluorescence analysis with anti-myc showing cytoplasmic expression of aA- and aB-crystallins in 661W cells transduced with the
corresponding recombinant lentiviruses. Cell nuclei were counterstained with DAPI and GFP staining was shown as a control of transduction
efficiency. pEF1a: EF1a promoter; IRES: internal ribosome entry site from encephalomyocarditis virus.
doi:10.1371/journal.pone.0055372.g005
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translocation to the mitochondria. In support of this, the
overexpressed aA- and aB-crystallins were essentially localized in
the cytoplasm of the transfected cells. In lens-derived epithelial cell
line, a-crystallins have been shown to inhibit STS-induced
apoptosis through interactions with members of the Bcl-2 family.
Through binding to Bax and Bcl-Xs, aA- and aB-crystallins
prevented the translocation of the pro-apoptotic proteins from
cytosol into mitochondria, repressing the release of cytochrome C
and the activation of Caspase-3 upon STS treatment [13].
Pasupuleti et al. demonstrated in HeLa and CHO cells that aA-
crystallin inhibited Caspase-9 and Caspase-3 activity and prevent-
ed chemically-triggered apoptosis as well as apoptosis induced by
over-expression of pro-apoptotic Bim and Bax. In these cells, aA-
crystallin-mediated anti-apoptotic function was directly related to
its chaperone activity by enhancing PI3K/Akt survival pathway
and reducing phosphatase tensin homologue (PTEN) activity [10].
During ER stress-induced retinal pigment epithelial (RPE) cell
apoptosis, aB-crystallin has been shown to protect cells against
mitochondrial dysfunction by inhibiting Bax and CHOP upregu-
lation, attenuating caspase activation and restoring mitochondrial
permeability transition [47]. McGreal and colleagues also reported
that aB-crystallin interacted with cytochrome C and preserved
mitochondrial membrane potential under oxidative stress [48].
Additionally, in mouse retinal explants exposed to oxidative stress,
RPE-secreted aB-crystallin was able to provide neuroprotection to
Figure 6. STS-induced apoptosis was prevented in 661W cells in the presence of a-Crystallins. 661W cells transduced with the
recombinant lentiviruses overexpressing aA-crystallin (pWPI_aA), aB-crystallin (pWPI_aB) or the empty lentivirus (pWPI) were treated with 100 nM
STS for 16 h. (A) STS-triggered apoptosis was inhibited in the presence of a-crystallins, as reflected by TUNEL assay using TMR-dUTP. (B) STS-induced
caspase activation was decreased in 661W cells overexpressing aA- and aB-crystallins, as measured by colorimetric Caspase-3/-7 assay. (* p,0.005 by
t-test for pWPI versus pWPIaA). Data are the mean 6 SE of four independent experiments.
doi:10.1371/journal.pone.0055372.g006
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Figure 7. Generation and expression of aA-crystallin deletion mutants. (A) Schematic representation of the various deletion mutants of aA-
crystallin. (B) Western blot and (C) immunofluorescence analyses in transiently transfected 293T cells showing expression of wt and mutant aA-
crystallin proteins fused to luciferase using luciferase antibody.
doi:10.1371/journal.pone.0055372.g007
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adjacent photoreceptor cells through inhibition of Caspase-3 and
PARP activation [49].
Several studies reported on altered expression of a-crystallins in
inherited retinal diseases [28,30], light-induced retinal degenera-
tion [32] as well as early- and late-stage ARMD [33,50–52]. It is
thus tempting to speculate that a-crystallins may be involved in the
development of these degenerative diseases. However, their role in
inherited retinal degeneration has not been studied yet and the
molecular mechanisms that may regulate a-crystallin-mediated
protection against photoreceptor apoptosis remain unknown. This
prompted us to assess the cytoprotective role of a-crystallins in the
survival of photoreceptor-like 661W cells. We reported a dose-
dependent decrease in cellular viability following STS treatment in
lentiviral-mediated 661W cells stably expressing aA- or aB-
crystallin, as reflected by increased TUNEL-positive apoptotic
cells and decreased cellular ATP content. Moreover, we showed
that a-crystallins prevented apoptosis through the inhibition of
Caspase-3/-7 activity. It has been shown in vivo in aA2/2-
crystallin and aB2/2-crystallin knock-out mice that RPE lacking
a-crystallins was more susceptible to apoptosis when subjected to
H2O2-induced oxidative stress, highlighted by increased Caspase-3
activation and elevated mitochondrial permeability transition [53].
Similarly, retinal degeneration induced by CoCl2-mediated
chemical hypoxia was exacerbated in retina deficient for aA- or
aB-crystallin, resulting in earlier and augmented apoptosis in inner
and outer nuclear layers and in RPE [34]. aA- and aB-crystallins
were described to accumulate in Bruch’s membrane-choroid
complex in ARMD patients, suggesting that their accumulation
reflects disease-related stress response during progression of the
disease [33]. Moreover, aB-crystallin displayed a pro-survival
effect in RPE in response to Caspase-3-dependent oxidant-
mediated apoptotic cell death, suggesting its involvement as a
stress-inducible anti-apoptotic protein in the pathogenesis of
ARMD [20]. In early experimental autoimmune uveitis (EAU),
increased levels of aA-crystallin were reported, while aB-crystallin
was not altered [35]. The upregulated aA-crystallin was mostly
localized in photoreceptor inner segments that are the site of
mitochondrial oxidative stress. aA-crystallin suppressed apoptosis
in early EAU through interaction with nitrated Cytochrome c and
through inhibition of autoproteolytic maturation of pro-Caspase-3.
Figure 8. The C-terminal extension domain of aA-crystallin was sufficient to provide protection against Bax-induced apoptosis.
Twenty-four hours post-transfection, 293T cells transfected with Bax (Bax/pRluc) or with Bax and aA-crystallin wt or mutants were assayed in TUNEL
assay. Counting of TUNEL-positive apoptotic cells showed that aA_wt (Bax/aA_wt), aA_90-143 (Bax/aA_90-143) and aA_144-173 (Bax/aA_144-173)
significantly inhibited Bax-induced apoptosis, whereas N-terminal aA_1-89 (Bax/aA_1-89) and aA_1-116 (Bax/aA_1-116), along with aA_64-143 (Bax/
aA_64-143) containing the a-crystallin domain, did not prevent apoptosis. (* p,0.05, ** p,0.01, *** p,0.005 by t-test versus Bax/aA_wt). Data are
the mean 6 SE of two to three independent experiments.
doi:10.1371/journal.pone.0055372.g008
Figure 9. Interaction of the C-terminal extension domain of aA-
crystallin with Bax in vivo. 293T cells transiently transfected with the
empty vector (pRluc), full length aA- (aA_wt) or mutant aA- (aA_144-
173) crystallin were further treated with 100 nM STS for 3 h before co-
immunoprecipitation with anti-Bax antibody. The precipitated samples
were then sequentially probed by western blot using anti-aA/aB and
anti-Bax antibodies. IP: immunoprecipitated samples (left panels); CE:
20 mg of total proteins from whole cell extract (right panels).
doi:10.1371/journal.pone.0055372.g009
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Increased level of the protein was correlated with protection
against photoreceptor cell loss, indicating that aA-crystallin might
provide a protective mechanism against immune-mediated mito-
chondrial oxidative stress-induced photoreceptor apoptosis [35]. A
recent study showed that intravenous administration of aA-
crystallin prevented photoreceptor apoptosis and degeneration
during EAU, whereas aB-crystallin lacked any protective effect
[36]. Furthermore, administration of aA-crystallin caused reduced
expression of Th1 cytokines as well as Toll-like receptors and their
associated adaptators, suggesting that aA-crystallin-mediated
protection of photoreceptor loss is associated with systemic
suppression of both the adaptive and innate immune response.
a-Crystallins have also been reported to exert a neuroprotective
effect against retinal ganglion cell (RGC) degeneration. Indeed,
intravitreal administration of a-crystallins enhanced survival of
axotomized axons [54], while in vivo electroporation of aA- and
aB-crystallins favored survival of RGCs upon optic nerve injury
[55]. Altogether, these data indicate that a-crystallins may trigger
common as well as independent intracellular signals and may act
either independently or in concert to exert cytoprotective action,
depending on the cell type and the disease.
a-Crystallins are constituted of three distinct domains. Each of
these domains displays chaperone function which can depend on
post-translational modifications of the N-terminus including
oxidation, phosphorylation, deamidation, acetylation and trunca-
tion [26] [56]. The C-terminal extension is considered to
contribute to its chaperone-like activity [57], while the N-terminal
domains contain phosphorylation sites that are the targets of
various protein kinases [58]. Peptides derived from both aA- and
aB-crystallins have been shown to display anti-apoptotic proper-
ties in RPE cells upon oxidative stress [59]. However, Santhosh-
kumar et al. [60] also reported on aA-crystallin-derived peptide
accumulating in the aging lens and inhibiting the chaperone
activity of a-crystallin. To better understand the protein domain
sufficient to provide aA-crystallin-mediated anti-apoptotic effect.
we generated various deletion mutants. aA_1-116 and aA_117-
173 mutants were chosen because the R116C mutation of aA-
crystallin has been shown to reduce its anti-apoptotic activity
[13,14] and to weaken its interaction with Bax [13]. R116C point
mutation in aA-crystallin causes autosomal dominant congenital
cataract in humans [61]. Mao et al [13] previously reported that
the N-terminal aA_1-89 mutant did not interact with Bax and did
not protect from apoptosis. We refined this analysis and showed
that amino acids 90–143 and 144–173 of aA-crystallin were
sufficient to protect from Bax-induced apoptosis and were as
efficient as the full-length aA-crystallin. We confirmed that N-
terminal and showed that a-crystallin domains do not play a major
role in the anti-apoptotic properties of aA-crystallin in preventing
Bax-induced cell death. Characterization of these mutants allowed
us to identify a small aA-crystallin sequence of 29 amino acids
corresponding to the C-terminal extension of the protein that
retained its ability to bind Bax and to prevent apoptosis.
We previously reported downregulated expression of a-crystal-
lins in correlation with Bax-triggered apoptosis of photoreceptors
in Rpe652/2 mice [37]. In the current study, we further analyzed
the pro-survival action of a-crystallins against Bax-induced
apoptosis in various cell lines including the photoreceptor-like
661W cells. We demonstrated that a-crystallins exert anti-
apoptotic action against Bax-mediated and STS-induced apoptosis
and that they act through inhibition of downstream caspases.
Furthermore, we reported that the C-terminal extension domain
of aA-crystallin was sufficient to provide protection against Bax-
triggered apoptosis. However, further studies are needed to
address in vivo the cytoprotection of a-crystallins against photore-
ceptor cell death in retinal degeneration, and more specifically to
challenge whether they may be efficient to prevent Bax-dependent
rod apoptosis in Rpe65-related LCA disease. Detailed investigation
of a-crystallin-derived peptides may prove to be valuable toward
the development of therapeutic molecules for retinal diseases such
as inherited retinal degeneration and ARMD.
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